NPM1-mutant acute myeloid leukemia relapsing as acute lymphoblastic leukemia with clonal persistence of IDH1 mutation
- 13 February 2021
- journal article
- letter
- Published by Informa UK Limited in Leukemia & Lymphoma
- Vol. 62 (7), 1-5
- https://doi.org/10.1080/10428194.2021.1881510
Abstract
Acute myeloid leukemia (AML) is an aggressive leukemia with poor outcomes even among patients eligible for intensive anthracycline-based induction chemotherapy [1]. While complete remission (CR) is...Keywords
This publication has 17 references indexed in Scilit:
- Clonal evolution patterns in acute myeloid leukemia with NPM1 mutationNature Communications, 2019
- Lineage Switch Under Blinatumomab of a Relapsed Common ALL Co-Expressing Myeloid Markers without MLL RearrangementBlood, 2016
- Instructive Role of MLL-Fusion Proteins Revealed by a Model of t(4;11) Pro-B Acute Lymphoblastic LeukemiaCancer Cell, 2016
- CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticityNature Communications, 2016
- Validation and Implementation of a Custom Next-Generation Sequencing Clinical Assay for Hematologic MalignanciesThe Journal of Molecular Diagnostics, 2016
- Benefit of high-dose daunorubicin in AML induction extends across cytogenetic and molecular groupsBlood, 2016
- Improving outcomes for patients with acute myeloid leukemia in first relapse: A single center experienceAmerican Journal of Hematology, 2014
- Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemiaBlood, 2013
- Lineage switch in childhood acute leukemia: An unusual event with poor outcomeAmerican Journal of Hematology, 2012
- Anthracycline Dose Intensification in Acute Myeloid LeukemiaNew England Journal of Medicine, 2009